Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036837 | SCV000060492 | benign | not specified | 2011-04-26 | criteria provided, single submitter | clinical testing | The Arg265Gly variant in DFNB59 has been reported in 4/30 probands with SNHL and 17/200 control chromosomes (Hashmzadeh-Chaleshtori, 2007), and was reported at a frequency of 1.7% in the Yoruba population in dbSNP (rs17304212). Therefore, t his variant is not expected to have clinical significance due to equal occurrenc e in probands and controls. |
Prevention |
RCV000036837 | SCV000306307 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000036837 | SCV000716966 | benign | not specified | 2017-08-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV001135345 | SCV001295122 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 59 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001135345 | SCV001876666 | benign | Autosomal recessive nonsyndromic hearing loss 59 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002228121 | SCV002511366 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing |